EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of an antimicrobial stewardship intervention on carbapenem use in children with cancer

Sarina K Butzer, Katrin Mehler, André Oberthuer, Lena M Biehl, Benjamin Kuehne, Pablo Landgraf, Thorsten Simon, Norma Jung

Infection · 2026-08 · 54 (4) · 1931-1943

DOI: 10.1007/s15010-026-02813-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection, online erschienen am 01.06.2026. Verfasst von Sarina K Butzer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Infectious Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Colo…. Hauptthemen laut MEDLINE: Neoplasms, Antimicrobial Stewardship, Anti-Bacterial Agents, Carbapenems. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Köln.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Infections during neutropenia are​ a potentially life-threatening complication​ in pediatric oncology. International guidelines recommend antipseudomonal β-lactam monotherapy for stable patients, however, modification​ to carbapenems often occurs without confirmed infection.​ Methods We conducted​ a retrospective cohort study​ at​ a single tertiary pediatric oncology center to assess the impact​ of​ a carbapenem-sparing AMS intervention​ in children during neutropenia. All pediatric cancer patients with​ at least one episode​ of​ suspected infection between January 2021 and October 2024 were included.​ The intervention combined training, updated standard operating procedures, multidrug-resistant (MDR) surveillance swabs, and​ a structured protocol reassessing meropenem treatment​.

Results

Among 254 patients, 116 met the inclusion criteria, accounting for 432​ episodes (270 pre- and 162 post-intervention). Re-modification​ of antimicrobial therapy from meropenem​ to piperacillin/tazobactam was achieved​ in​ 16​ of​ 50 post-intervention episodes. The median duration​ of meropenem treatment decreased from​ 9​ to​ 6 days​ ( p​ = 0.006 ). Interrupted time series analysis showed​ a non-significant reduction​ in meropenem use, corresponding​ to​ an estimated decline​ of 40.7 days of therapy (DOT) per 1000 patient-days per quarter. Mortality was unchanged (3.8%​ vs 4.3%).

Conclusion

Our findings demonstrate that a structured AMS intervention is feasible and effective​ in pediatric oncology, reducing unnecessary meropenem exposure without compromising safety. While this approach may serve​ as​ a model for broader multicenter efforts​ to promote individualized, evidence-based antimicrobial use, the low number​ of blood stream infections (BSI)​ in our cohort limits the ability​ to draw definitive conclusions about the clinical impact​ of MDR screening​ on infection-related outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntimicrobial StewardshipAnti-Bacterial AgentsCarbapenemsHumansRetrospective StudiesChildFemaleMaleChild, PreschoolAdolescentMeropenemInfantNeutropenia

Stichwörter der Autor:innen

Antimicrobial stewardshipChildren with cancerFebrile neutropeniaInfections in pediatric oncology

Substanzen

Anti-Bacterial AgentsCarbapenemsMeropenem

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Pediatric Infectious Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. sarina.butzer@uk-koeln.de.
  • Department of Pediatrics, Division of Pediatric Hematology and Oncology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. sarina.butzer@uk-koeln.de.
  • Department of Pediatrics, Division of Pediatric Infectious Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Department of Internal Medicine I, Division of Infectious Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • German Centre for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany.
  • Department of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Förderung

  • Universitätsklinikum Köln

Zitieren

APA

Butzer, S. K., Mehler, K., Oberthuer, A., Biehl, L. M., Kuehne, B., Landgraf, P., Simon, T., & Jung, N. (2026). Impact of an antimicrobial stewardship intervention on carbapenem use in children with cancer. Infection, 54(4), 1931-1943. https://doi.org/10.1007/s15010-026-02813-y

Vancouver

Butzer SK, Mehler K, Oberthuer A, Biehl LM, Kuehne B, Landgraf P, et al. Impact of an antimicrobial stewardship intervention on carbapenem use in children with cancer. Infection. 2026;54(4):1931-1943. doi:10.1007/s15010-026-02813-y

BibTeX
@article{Butzer2026,
  author = {Butzer, Sarina K and Mehler, Katrin and Oberthuer, André and Biehl, Lena M and Kuehne, Benjamin and Landgraf, Pablo and Simon, Thorsten and Jung, Norma},
  title = {Impact of an antimicrobial stewardship intervention on carbapenem use in children with cancer},
  journal = {Infection},
  year = {2026},
  volume = {54},
  number = {4},
  pages = {1931--1943},
  doi = {10.1007/s15010-026-02813-y}
}
Kostenlos starten →